EXHIBIT 8
Dr. Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries, joint ventures and associates as of March 31, 2026:
Name of the subsidiaries/associates/joint ventures | Country of Incorporation | Percentage of Direct/Indirect Ownership Interest |
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. | Malaysia | 100%(1) |
Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited) | India | 100% |
Aurigene Pharmaceutical Services Limited | India | 100%(1) |
beta Institut gemeinnützige GmbH | Germany | 100%(6) |
betapharm Arzneimittel GmbH | Germany | 100%(6) |
Cheminor Investments Limited | India | 100% |
Dr. Reddy’s Farmaceutica Do Brasil Ltda. | Brazil | 100% |
Dr. Reddy’s Laboratories (EU) Limited | United Kingdom | 100%(7) |
Dr. Reddy’s Laboratories (Proprietary) Limited | South Africa | 100%(7) |
Dr. Reddy’s Laboratories (UK) Limited | United Kingdom | 100%(3) |
Dr. Reddy’s Laboratories Canada, Inc. | Canada | 100%(7) |
Dr. Reddy’s Laboratories Chile SPA. | Chile | 100%(7) |
Dr. Reddy’s Laboratories Inc. | U.S.A. | 100%(7) |
Dr. Reddy’s Laboratories Japan KK | Japan | 100%(7) |
Dr. Reddy’s Laboratories Kazakhstan LLP | Kazakhstan | 100%(7) |
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd. | Malaysia | 100%(7) |
Dr. Reddy’s Laboratories New York, LLC | U.S.A. | 100%(4) |
Dr. Reddy’s Laboratories Philippines Inc. | Philippines | 100%(7) |
Dr. Reddy’s Laboratories Romania Srl | Romania | 100%(7) |
Dr. Reddy’s Laboratories SA | Switzerland | 100% |
Dr. Reddy’s Laboratories Taiwan Limited | Taiwan | 100%(7) |
Dr. Reddy’s Laboratories (Thailand) Limited | Thailand | 100%(7) |
Dr. Reddy’s Laboratories LLC, Ukraine | Ukraine | 100%(7) |
Dr. Reddy’s New Zealand Limited. | New Zealand | 100%(7) |
Dr. Reddy’s Srl | Italy | 100%(8) |
Dr. Reddy’s Bio-Sciences Limited | India | 100% |
Dr. Reddy’s Laboratories (Australia) Pty. Limited | Australia | 100%(7) |
Dr. Reddy’s Laboratories SAS | Colombia | 100%(7) |
Dr. Reddy's Netherlands B.V. (formerly Dr. Reddy’s Research and Development B.V.) | Netherlands | 100%(9) |
Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited | China | 100%(7) |
DRES Energy Private Limited | India | 26%(10) |
DRL Impex Limited | India | 100%(11) |
Dr. Reddy’s Formulations Limited | India | 100% |
Idea2Enterprises (India) Pvt. Limited | India | 100% |
Imperial Owners and Land Possessions Private Limited (Formerly, Imperial Credit Private Limited) (Dissolved on August 5, 2025) | India | 100% |
Industrias Quimicas Falcon de Mexico, S.A. de CV | Mexico | 100% |
Kunshan Rotam Reddy Pharmaceutical Co. Limited | China | 51.33%(2) |
Lacock Holdings Limited | Cyprus | 100%(7) |
Dr. Reddy’s Laboratories LLC | Russia | 100%(7)(14) |
Promius Pharma LLC | U.S.A. | 100%(4) |
Reddy Holding GmbH | Germany | 100%(7) |
Reddy Netherlands B.V. | Netherlands | 100%(7) |
Reddy Pharma Iberia SAU | Spain | 100%(7) |
Reddy Pharma Italia S.R.L. | Italy | 100%(5) |
Reddy Pharma SAS | France | 100%(7) |
Svaas Wellness Limited (Divested on April 7, 2026) | India | 100% |
Nimbus Health GmbH | Germany | 100%(6) |
Dr. Reddy’s Laboratories Jamaica Limited | Jamaica | 100%(7) |
O2 Renewable Energy IX Private Limited | India | 26%(10) |
Dr. Reddy’s and Nestle Health Science Limited (Formerly, Dr. Reddy’s Nutraceuticals Limited) (Refer to Note 35.A of these consolidated financial statements for further details) | India | 51% |
Dr. Reddy’s Employees ESOS Trust | India | Refer to below footnote(13) |
Name of the subsidiaries/associates/joint ventures | Country of Incorporation | Percentage of Direct/Indirect Ownership Interest |
Cheminor Employees Welfare Trust | India | Refer to below footnote(13) |
Dr. Reddy’s Research Foundation | India | Refer to below footnote(13) |
Clean Renewable Energy KK 2A Private Limited (From July 31, 2024) | India | 26.99%(10) |
Northstar Switzerland SARL (From September 30, 2024) | Switzerland | 100%(7) |
North Star OpCo Limited (From September 30, 2024) | United Kingdom | 100%(12) |
North Star Sweden AB (From September 30, 2024) | Sweden | 100%(12) |
Dr. Reddy's Denmark ApS (From October 4, 2024) | Denmark | 100%(7) |
Dr. Reddy’s Finland Oy (From December 20, 2024) | Finland | 100%(7) |
Kunshan Rotam Reddy Medicine Company Limited | China | 51.33%(2)(15) |
Dr. Reddy’s Laboratories (Vietnam) Company Limited (From May 9, 2025) | Vietnam | 100%(7) |
(1) | Indirectly owned through Aurigene Oncology Limited (Formerly, Aurigene Discovery Technologies Limited). |
(2) | Kunshan Rotam Reddy Pharmaceutical Co. Limited and Kunshan Rotam Reddy Medicine Company Limited are subsidiaries as per the Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment in accordance with IFRS 11, “Joint Arrangements” using the equity method and does not consolidate it in the Company’s financial statements. |
(3) | Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited. |
(4) | Indirectly owned through Dr. Reddy’s Laboratories Inc. |
(5) | Indirectly owned through Lacock Holdings Limited. |
(6) | Indirectly owned through Reddy Holding GmbH. |
(7) | Indirectly owned through Dr. Reddy’s Laboratories SA. |
(8) | Indirectly owned through Reddy Pharma Italia S.R.L. |
(9) | Indirectly owned through Reddy Netherlands B.V. |
(10) | Accounted for using the equity method as per IAS 28, “Investments in Associates and Joint Ventures”. |
(11) | Indirectly owned through Idea2Enterprises (India) Pvt. Limited. |
(12) | Indirectly owned through Northstar Switzerland SARL. |
(13) | The Company does not have any equity interests in this entity but has significant influence or control over it. |
(14) | 45.19% held directly by Dr. Reddy’s Laboratories Limited. |
(15) | Indirectly owned through Kunshan Rotam Reddy Pharmaceutical Co. Limited. |